Thrombin-induoed vascular injury through the overproduction of reactive oxygen species

活性氧过量产生凝血酶引起的血管损伤

基本信息

  • 批准号:
    12670674
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

To clarify the effect of thrombin on the production of reactive oxygen species (ROS) in vasular endothelial cells, we analyzed intracellular amount of hydrogen peroxide in cultured human umbilical vein endothelial cells (HUVEC) using the fluorescence probe (DCFH-DA). In HUVEC, ROS was increased up to two-folds of control by the treatment of 1U/ml thrombin for 24 hours. Carbonyl cyanide m-chlorophenylhyazone, an agent for decreasing the mitochondrial membrane proton gradient and thenoyltrifluoroacetone, a complex II inhibitor, markedly suppressed the overproduction of ROS in thrombin-treated HUVEC. Quinacrine, an inhibitor for NADPH oxidase, also significantly suppressed the overproduction of ROS. In contrast, no significant inhibitory effects of indomethacin, an inhibitor for cyclooxygenase, or of L-NAME, an inhibitor for NO synthase, were observed. DPI, an inhibitor for complex I, and myxothiazol, an inhibitor for complex III, also did not exhibit a significant effect on the production of ROS. Con focal laser microscopy imaging showed that green fluoresscence of DCFH-DA colocalized with red fluorescence of Mitotracker Red, indicating hydrogen peroxide production from mitochondria. Pre-treatment of aspirin (1mM) markedly suppressed the ROS production in thrombin-treated HUVEC.These findings showed that thrombin could cause the overproduction of ROS from mitochondrial respiratory chain and NADPH oxidase, and subsequently the consumption of NO in vascular endothelial cells, leading to injury of vscular endothelial cells. In addition, aspirin may protect vascular endothelial cells from damage by trombin-induced ROS poduction.
为探讨凝血酶对血管内皮细胞活性氧(ROS)产生的影响,采用荧光探针DCFH-DA检测了培养的人脐静脉内皮细胞(HUVEC)细胞内过氧化氢(H2 O2)的含量。1U/ml凝血酶作用HUVEC 24小时,ROS水平增加至对照组的2倍。羰基氰化物间氯苯腙,用于降低线粒体膜质子梯度和噻吩甲酰三氟丙酮,复合物II抑制剂的代理,显着抑制凝血酶处理的HUVEC中的ROS的过度产生。奎纳克林,NADPH氧化酶的抑制剂,也显着抑制ROS的过度产生。与此相反,没有显着的抑制作用,吲哚美辛,环氧合酶的抑制剂,或L-NAME,一氧化氮合酶的抑制剂,观察。复合物I的抑制剂DPI和复合物III的抑制剂myxothiazol也没有表现出对ROS产生的显著影响。共聚焦激光显微镜成像显示DCFH-DA的绿色荧光与Mitotracker Red的红色荧光共定位,表明线粒体产生过氧化氢。阿司匹林(1 mM)预处理可明显抑制凝血酶处理的HUVEC产生ROS,提示凝血酶可引起HUVEC线粒体呼吸链和NADPH氧化酶产生ROS,进而消耗NO,导致血管内皮细胞损伤。此外,阿司匹林可保护血管内皮细胞免受Trombin诱导的ROS产生的损伤。

项目成果

期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kuroda Y. et al.: "Homozygous deletion mutation of the parkin gene in patients with atypical parkinsonism"J Neurol Neurosurg Psychiatry. 71. 231-234 (2001)
Kuroda Y. 等人:“非典型帕金森病患者的帕金基因纯合缺失突变”J Neurol Neurosurg Psychiatry。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Umaki Y, et al.: "Apoptosis-related changes in skeletal muscles of patients with mitochondrial diseases"Acta Neuropathol. 103. 163-170 (2002)
Umaki Y 等人:“线粒体疾病患者骨骼肌细胞凋亡相关的变化”Acta Neuropathol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanagawa Y, et al.: "Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation at reactive P2 site : HC II Tokushima"Thromb Haemost. 85. 101-107 (2001)
Kanakawa Y 等人:“由反应性 P2 位点错义突变引起的 I 型先天性肝素辅因子 (HC) II 缺乏症的分子机制:HC II 德岛”血栓 Haemost。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Aihara K, et al.: "Successful combination therapy-Flunarizine, pentoxifyline, and Cholestyramine-For spur cell anemia"Int J Hematol. 73. 351-355 (2001)
Aihara K 等人:“成功的联合疗法——氟桂利嗪、己酮可可碱和考来烯胺——治疗刺激细胞贫血”Int J Hematol。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kanagawa Y,Shigekiyo T,Aihara K,Akaike M, et al.: "Molecular mechanism of type I congenital heparin cofactor (HC) II deficiency caused by a missense mutation of reactive P2 site : HC II Tokushima"Thromb Haemost. 85. 101-107 (2001)
Kanakawa Y、Shigekiyo T、Aihara K、Akaike M 等人:“由反应性 P2 位点错义突变引起的 I 型先天性肝素辅因子 (HC) II 缺乏症的分子机制:HC II 德岛”血栓 Haemost。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AKAIKE Masashi其他文献

AKAIKE Masashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AKAIKE Masashi', 18)}}的其他基金

Development of training program introducing clinical clerkship to acquire 360 degree communication skills and abilities
制定临床实习培训计划,以获取 360 度沟通技巧和能力
  • 批准号:
    15K08554
  • 财政年份:
    2015
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Glucocorticoid-induced vascular endothelial dysfunction through activation of mineralcorticoid receptor
糖皮质激素通过激活盐皮质激素受体诱导血管内皮功能障碍
  • 批准号:
    21590955
  • 财政年份:
    2009
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel therapeutic strategy for glucocorticoid-induced vascula endothelial dysfundtion
糖皮质激素引起的血管内皮功能障碍的新治疗策略
  • 批准号:
    19590866
  • 财政年份:
    2007
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel regulatory mechanism of vascular endothelial function mediated by BMK1/ERK5 and its application for anti-atherosclerosis therapy
BMK1/ERK5介导的血管内皮功能调控新机制及其在抗动脉粥样硬化治疗中的应用
  • 批准号:
    17590740
  • 财政年份:
    2005
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of cardiovascular complications by the production of reactive oxygen species from mitochondria in patients with glucocrticoid excess
糖皮质激素过量患者线粒体产生活性氧引起的心血管并发症分析
  • 批准号:
    10670663
  • 财政年份:
    1998
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

The role of cellular senescence of vascular endothelial cells in idiopathic pulmonary fibrosis and complicated pulmonary hypertension.
血管内皮细胞衰老在特发性肺纤维化和复杂性肺动脉高压中的作用。
  • 批准号:
    23K15189
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of in vitro intravasation/extravasation model for understanding the interaction between cancer and vascular endothelial cells at the cellular and molecular levels
开发体外渗入/渗出模型,以在细胞和分子水平上了解癌症与血管内皮细胞之间的相互作用
  • 批准号:
    23KJ0490
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Effects of neutrophil extracellular traps and lipoproteins on the function of vascular endothelial cells
中性粒细胞胞外陷阱和脂蛋白对血管内皮细胞功能的影响
  • 批准号:
    23K10897
  • 财政年份:
    2023
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Characterization of regulation and functions of tricellulin in vascular endothelial cells
三纤维素蛋白在血管内皮细胞中的调节和功能的表征
  • 批准号:
    RGPIN-2019-04714
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Discovery Grants Program - Individual
Effects of cadmium on tight junction of vascular endothelial cells: clarification of the mechanism of detachment injury
镉对血管内皮细胞紧密连接的影响:阐明脱离损伤机制
  • 批准号:
    22K17355
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Cooperation of neural crest cells, macrophages, and vascular endothelial cells during cardiac development.
心脏发育过程中神经嵴细胞、巨噬细胞和血管内皮细胞的合作。
  • 批准号:
    22K07877
  • 财政年份:
    2022
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the molecular mechanisms underlying the aging process in vascular endothelial cells.
血管内皮细胞衰老过程的分子机制分析。
  • 批准号:
    21K20741
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
ADAMTS13 gene polymorphism genome editing creation of vascular endothelial cells and exploration for new leukemia therapies
ADAMTS13基因多态性基因组编辑血管内皮​​细胞创建及白血病新疗法探索
  • 批准号:
    21K08427
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Vascular endothelial cells and macrophages coordinate neutrophil trafficking in inflammation
血管内皮细胞和巨噬细胞协调炎症中的中性粒细胞运输
  • 批准号:
    10418796
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
Vascular endothelial cells and macrophages coordinate neutrophil trafficking in inflammation
血管内皮细胞和巨噬细胞协调炎症中的中性粒细胞运输
  • 批准号:
    10298564
  • 财政年份:
    2021
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了